Description
An inhibitor of Akt activation; inhibits Akt-mediated nuclear export of FOXO1a (IC50 = 625 nM) and reduces phosphorylation of Akt at Ser473 and Thr308 in a dose-dependent manner; inhibits replication of PIV5 in HeLa cells (IC50 = 520 nM); reduces the growth of cancer cells (IC50 = 0.3 μM for both Jurkat and HeLa cells) via a reduction in mitochondrial polarization and increased production of ROS
Formal name: 6-(2-benzothiazolyl)-1-ethyl-2-[2-(methylphenylamino)ethenyl]-3-phenyl-1H-benzimidazolium, monoiodide
Synonyms:
Molecular weight: 614.6
CAS: 681281-88-9
Purity: ≥95%
Formulation: A crystalline solid
Product Type|Biochemicals|Antivirals||Product Type|Biochemicals|Kinase Inhibitors|PKB/Akt||Product Type|Biochemicals|Small Molecule Inhibitors|Kinases||Research Area|Cancer|Cell Cycle|G2/M||Research Area|Cancer|Cell Cycle|G2/S||Research Area|Cancer|Tumor Microenvironment||Research Area|Immunology & Inflammation||Research Area|Infectious Disease|Viral Diseases|Influenza